ArticleJournal of community hospital internal medicine perspectives2026
ALK-negative Anaplastic Large Cell Lymphoma Presenting as Back Pain.
Article in Journal of community hospital internal medicine perspectives, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma (ALCL) is a distinct subtype of mature T-cell non-Hodgkin lymphoma characterized by large, strongly positive CD30 lymphoid cells that lack expression and rearrangement of the ALK gene. Here, we present a unique case of ALK-negative ALCL in a 34-year-old male patient who presented with acute on chronic back pain. Initial emergent MRI spine demonstrated lytic changes of L3 and L4 with probable psoas fluid collection, with high suspicion for Pott's disease. However, subsequent work-up including a CT-guided bone biopsy revealed ALK-negative ALCL. Patient underwent radiation to his lumbar spine and psoas muscle, with good radiographic response in those areas, however, further imaging with PET/CT showed widespread metastatic disease. Considering the burden of his disease, the patient received chemotherapy with BV-CHP, and achieved good response to therapy notable on his repeat PET/CT after his third cycle. Unfortunately, due to insurance coverage, patient transitioned his care to a different facility and no further information could be obtained. This case highlights an infrequent and unique presentation of ALK-negative ALCL, where progressive lumbar back pain in a young individual without B symptoms or lymphadenopathy warranted additional diagnostic workup for malignancy without anchoring to common diagnoses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.